With plans for a major expansion of its site North Carolina, Fresenius Kabi's investments aimed mainly at the U.S. generics market now top $5 billion.
AmerisourceBergen has added $50 million more to resolve a DOJ probe into sales of cancer meds, taking its total in the matter to $885 million.
There’s no stopping time…but these Patient Recruitment & Retention tactics can help overcome trial delays. Our global late-stage study expert discusses…
Here's your pharma manufacturing news of note.
AmerisourceBergen will extend its reach with an $815 million deal to buy independent drug distributor H. D. Smith.
Pfizer is in a tug of war with several states that intend to use some of its drugs to carry out executions.
With a U.S. saline shortage intensifying, the FDA is getting Baxter preferential treatment in having power restored to saline plants in Puerto Rico.
B. Braun, one of three main saline suppliers, is closing a plant for maintenance, a move it acknowledges will make a bad supply situation worse.
Cardinal Health has agreed to sell its China business to Shanghai Pharma for $557 million in cash.
Merck and GSK are coping with hepatitis A vaccine shortages as the U.S. is experiencing deadly outbreaks.